Matt Klinman on How Facebook is Ruining Online Creativity
Matt Klinman is a comedian who has been working in comedy for companies like Funny or Die for years. Recently, the comedy site had to lay off many people in their video department. Klinman spoke with Cheddar about the reason many media companies are laying off social video departments and how these companies can refocus their goals to leave Facebook behind.
Klinman discusses the idea that companies need to change directions to focus more on long format and veer away from social video in order to survive the changes made online. He also discusses the idea that Facebook has created centrally designed internet that is basically ruining online creativity.
Klinman argues that this model is bad for all publishers, including Facebook itself. He also asserts that it's basically impossible to run a large independent creative outfit on the internet now and says publishers should leave Facebook or attempt to organize to get leverage to get Facebook to pay them.
Ben Geman, Energy Reporter at Axios, joins to discuss the latest Middle East tensions, Brent crude price swings, and why gas prices aren’t falling with oil.
Al Root, Associate Editor at Barron's, joins to discuss Tesla’s robotaxis going live in Texas—what it means for autonomy, safety, and the EV race ahead.
Dena Jalbert, M&A expert and CEO of Align Business Advisory Services, on the state of U.S. M&A: deals worth $1–$10 billion (including debt) are surging.
Jeremy Jansen, Head of Supply Chain at Wells Fargo, unpacks the ongoing trade talks between the United States and China as consumers still wonder about tariffs.
IBM Fellow Jerry Chow talks IBM’s expansion of the Quantum Data Center in Poughkeepsie, installing Heron processors that deliver utility‑scale performance.
Ken Shepard, Head of Specialty Asset Management at Bank of America, discusses the importance of real assets and unpacks the bank's specialty asset outlook.
Cardinal Health's Debbie Weitzman explains how the company's Advanced Therapy Solutions Innovation Center aims to improve access to specialty medicines. Watch!
